{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T13:26:53Z","timestamp":1781184413626,"version":"3.54.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003851","name":"Heilongjiang Province Department of Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003851","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014902","name":"Jiamusi University","doi-asserted-by":"publisher","award":["JDXKTD-2019003"],"award-info":[{"award-number":["JDXKTD-2019003"]}],"id":[{"id":"10.13039\/501100014902","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.intimp.2021.108264","type":"journal-article","created":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T21:28:09Z","timestamp":1635456489000},"page":"108264","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"PA","title":["Topoisomerase 2 inhibitor etoposide promotes interleukin-10 production in LPS-induced macrophages via upregulating transcription factor Maf and activating PI3K\/Akt pathway"],"prefix":"10.1016","volume":"101","author":[{"given":"Jiaxin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoxin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yili","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengxia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiliang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7203","key":"10.1016\/j.intimp.2021.108264_b0005","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/nature07201","article-title":"Origin and physiological roles of inflammation","volume":"454","author":"Medzhitov","year":"2008","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.intimp.2021.108264_b0010","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1038\/ni1274","article-title":"Limiting inflammatory responses during activation of innate immunity","volume":"6","author":"Han","year":"2005","journal-title":"Nat. Immunol."},{"issue":"7","key":"10.1016\/j.intimp.2021.108264_b0015","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.autrev.2010.12.006","article-title":"Inflammation as \u201ccommon soil\u201d of the multifactorial diseases","volume":"10","author":"Scrivo","year":"2011","journal-title":"Autoimmun. Rev."},{"issue":"5","key":"10.1016\/j.intimp.2021.108264_b0020","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.cbpa.2007.08.012","article-title":"Natural products as a screening resource","volume":"11","author":"Harvey","year":"2007","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"4","key":"10.1016\/j.intimp.2021.108264_b0025","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.immuni.2019.03.020","article-title":"IL-10 Family Cytokines IL-10 and IL-22: from Basic Science to Clinical Translation","volume":"50","author":"Ouyang","year":"2019","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.intimp.2021.108264_b0030","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev.immunol.19.1.683","article-title":"Interleukin-10 and the interleukin-10 receptor","volume":"19","author":"Moore","year":"2001","journal-title":"Annu. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2021.108264_b0035","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0165-2478(03)00002-6","article-title":"IL-10, an inflammatory\/inhibitory cytokine, but not always","volume":"86","author":"Conti","year":"2003","journal-title":"Immunol. Lett."},{"issue":"1-3","key":"10.1016\/j.intimp.2021.108264_b0040","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s12026-009-8150-5","article-title":"Cell type-specific regulation of IL-10 expression in inflammation and disease","volume":"47","author":"Hedrich","year":"2010","journal-title":"Immunol. Res."},{"issue":"6","key":"10.1016\/j.intimp.2021.108264_b0045","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.immuni.2018.12.001","article-title":"The Biology of T Regulatory Type 1 Cells and Their Therapeutic Application in Immune-Mediated Diseases","volume":"49","author":"Roncarolo","year":"2018","journal-title":"Immunity"},{"issue":"8","key":"10.1016\/j.intimp.2021.108264_b0050","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/s41584-021-00648-5","article-title":"Lyme arthritis: linking infection, inflammation and autoimmunity","volume":"17","author":"Lochhead","year":"2021","journal-title":"Nat. Rev. Rheumatol."},{"issue":"1","key":"10.1016\/j.intimp.2021.108264_b0055","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/imr.12835","article-title":"Using two phases of the CD4 T cell response to blood-stage murine malaria to understand regulation of systemic immunity and placental pathology in Plasmodium falciparum infection","volume":"293","author":"Gbedande","year":"2020","journal-title":"Immunol. Rev."},{"issue":"9","key":"10.1016\/j.intimp.2021.108264_b0060","doi-asserted-by":"crossref","first-page":"713","DOI":"10.2174\/1568026619666190401112948","article-title":"Topoisomerase Inhibitors and Targeted Delivery in Cancer Therapy","volume":"19","author":"You","year":"2019","journal-title":"Curr Top Med Chem"},{"issue":"2","key":"10.1016\/j.intimp.2021.108264_b0065","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1042\/BCJ20160583","article-title":"Topoisomerases as anticancer targets","volume":"475","author":"Delgado","year":"2018","journal-title":"Biochem J."},{"issue":"9","key":"10.1016\/j.intimp.2021.108264_b0070","doi-asserted-by":"crossref","first-page":"730","DOI":"10.2174\/1568026619666190401113350","article-title":"Recent Advances in Use of Topoisomerase Inhibitors in Combination Cancer Therapy","volume":"19","author":"Wang","year":"2019","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.intimp.2021.108264_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104368","article-title":"Nitidine chloride exerts anti-inflammatory action by targeting Topoisomerase I and enhancing IL-10 production","volume":"148","author":"Yang","year":"2019","journal-title":"Pharmacol. Res."},{"issue":"6289","key":"10.1016\/j.intimp.2021.108264_b0080","doi-asserted-by":"crossref","first-page":"p. aad7993","DOI":"10.1126\/science.aad7993","article-title":"Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation","volume":"352","author":"Rialdi","year":"2016","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.intimp.2021.108264_b0085","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1016\/j.cell.2021.03.051","article-title":"TOP1 inhibition therapy protects against SARS-CoV-2-induced lethal inflammation","volume":"184","author":"Ho","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2021.108264_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2020.110180","article-title":"The AI-discovered aetiology of COVID-19 and rationale of the irinotecan+ etoposide combination therapy for critically ill COVID-19 patients","volume":"144","author":"Lovetrue","year":"2020","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.intimp.2021.108264_b0095","article-title":"A novel anti-c-Kit antibody-drug conjugate to treat wild-type and activating-mutant c-Kit-positive tumors","author":"Kim","year":"2021","journal-title":"Mol Oncol"},{"key":"10.1016\/j.intimp.2021.108264_b0100","article-title":"Anaphylactic shock in a small cell lung cancer patient receiving atezolizumab therapy: a rare but potentially fatal complication","author":"Zhao","year":"2021","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.intimp.2021.108264_b0105","doi-asserted-by":"crossref","DOI":"10.6004\/jnccn.2020.7796","article-title":"Cost-Effectiveness Analysis of Durvalumab Plus Chemotherapy in the First-Line Treatment of Extensive-Stage Small Cell Lung Cancer","author":"Ding","year":"2021","journal-title":"J. Natl. Compr. Canc. Netw."},{"issue":"6 Suppl 13","key":"10.1016\/j.intimp.2021.108264_b0110","first-page":"59","article-title":"Etoposide in gastric cancer","volume":"19","author":"Macdonald","year":"1992","journal-title":"Semin. Oncol."},{"issue":"S1","key":"10.1016\/j.intimp.2021.108264_b0115","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/1097-0142(19910101)67:1+<266::AID-CNCR2820671310>3.0.CO;2-A","article-title":"Etoposide in the management of metastatic breast cancer","volume":"67","author":"Sledge","year":"1991","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.intimp.2021.108264_b0120","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/COC.0000000000000804","article-title":"The Immunosuppression of Etoposide Deserves Attention in Chemoimmunotherapy","volume":"44","author":"Yang","year":"2021","journal-title":"Am. J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.intimp.2021.108264_b0125","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1158\/0008-5472.CAN-06-3782","article-title":"Akt1 Ablation Inhibits, whereas Akt2 Ablation Accelerates, the Development of Mammary Adenocarcinomas in Mouse Mammary Tumor Virus (MMTV)-ErbB2\/Neu and MMTV-Polyoma Middle T Transgenic Mice","volume":"67","author":"Maroulakou","year":"2007","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.intimp.2021.108264_b0130","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/cdd.2013.63","article-title":"Akt1 is the principal Akt isoform regulating apoptosis in limiting cytokine concentrations","volume":"20","author":"B.D.","year":"2013","journal-title":"Cell Death Differ"},{"issue":"6","key":"10.1016\/j.intimp.2021.108264_b0135","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.4049\/jimmunol.180.6.4218","article-title":"Genetic analysis of the role of the PI3K-Akt pathway in lipopolysaccharide-induced cytokine and tissue factor gene expression in monocytes\/macrophages","volume":"180","author":"J.P.","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2021.108264_b0140","first-page":"5517143","article-title":"Berbamine Inhibits Cell Proliferation and Migration and Induces Cell Death of Lung Cancer Cells via Regulating c-Maf, PI3K\/Akt, and MDM2-P53 Pathways","volume":"2021","author":"Liu","year":"2021","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.intimp.2021.108264_b0145","doi-asserted-by":"crossref","first-page":"29359","DOI":"10.1038\/srep29359","article-title":"Methane limit LPS-induced NF-kappaB\/MAPKs signal in macrophages and suppress immune response in mice by enhancing PI3K\/AKT\/GSK-3beta-mediated IL-10 expression","volume":"6","author":"Zhang","year":"2016","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.intimp.2021.108264_b0150","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1146\/annurev-immunol-031210-101312","article-title":"Regulation and functions of the IL-10 family of cytokines in inflammation and disease","volume":"29","author":"Ouyang","year":"2011","journal-title":"Annu. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2021.108264_b0155","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/nri2711","article-title":"The regulation of IL-10 production by immune cells","volume":"10","author":"Saraiva","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2021.108264_b0160","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.coi.2015.01.007","article-title":"Non-canonical activation of inflammatory caspases by cytosolic LPS in innate immunity","volume":"32","author":"Yang","year":"2015","journal-title":"Curr. Opin. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2021.108264_b0165","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1084\/jem.170.6.2081","article-title":"Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones","volume":"170","author":"Fiorentino","year":"1989","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.intimp.2021.108264_b0170","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.cvsm.2017.10.010","article-title":"Current and Newly Emerging Autoimmune Diseases","volume":"48","author":"Gershwin","year":"2018","journal-title":"Vet. Clin. North Am. Small Anim. Pract."},{"issue":"4","key":"10.1016\/j.intimp.2021.108264_b0175","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","volume":"8","author":"Xu","year":"2020","journal-title":"Lancet Respir. Med."},{"issue":"10223","key":"10.1016\/j.intimp.2021.108264_b0180","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.intimp.2021.108264_b0185","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/jmv.26232","article-title":"The cytokine storm and COVID-19","volume":"93","author":"Hu","year":"2021","journal-title":"J. Med. Virol."},{"issue":"7","key":"10.1016\/j.intimp.2021.108264_b0190","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1007\/s10067-020-05190-5","article-title":"Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment","volume":"39","author":"Soy","year":"2020","journal-title":"Clin. Rheumatol."},{"issue":"2","key":"10.1016\/j.intimp.2021.108264_b0195","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1124\/pr.55.2.4","article-title":"Interleukin-10 therapy\u2013review of a new approach","volume":"55","author":"Asadullah","year":"2003","journal-title":"Pharmacol. Rev."},{"issue":"9","key":"10.1016\/j.intimp.2021.108264_b0200","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/ni.1912","article-title":"The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27","volume":"11","author":"Apetoh","year":"2010","journal-title":"Nat. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2021.108264_b0205","doi-asserted-by":"crossref","first-page":"858","DOI":"10.3109\/08923973.2012.665461","article-title":"The PI3K\/Akt pathway is required for LPS activation of microglial cells","volume":"34","author":"Saponaro","year":"2012","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"10.1016\/j.intimp.2021.108264_b0210","first-page":"5517143","article-title":"Berbamine Inhibits Cell Proliferation and Migration and Induces Cell Death of Lung Cancer Cells via Regulating c-Maf, PI3K\/Akt, and MDM2-P53 Pathways","volume":"2021","author":"Liu","year":"2021","journal-title":"Evid Based Complement Alternat Med"},{"issue":"17","key":"10.1016\/j.intimp.2021.108264_b0215","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1016\/j.febslet.2005.04.086","article-title":"MafA transcription factor is phosphorylated by p38 MAP kinase","volume":"579","author":"Sii-Felice","year":"2005","journal-title":"FEBS Lett."},{"issue":"9","key":"10.1016\/j.intimp.2021.108264_b0220","first-page":"799","article-title":"The Th2 transcription factor c-Maf inhibits IL-12p35 gene expression in activated macrophages by targeting NF-kappaB nuclear translocation","volume":"27","author":"Homma","year":"2007","journal-title":"J. Interferon Cytokine Res."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921009000?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921009000?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:32:26Z","timestamp":1761586346000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576921009000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":44,"alternative-id":["S1567576921009000"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2021.108264","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Topoisomerase 2 inhibitor etoposide promotes interleukin-10 production in LPS-induced macrophages via upregulating transcription factor Maf and activating PI3K\/Akt pathway","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2021.108264","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108264"}}